!function(s,a,e,v,n,t,z){if(s.saq)return;n=s.saq=function(){n.callMethod?n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!s._saq)s._saq=n;n.push=n;n.loaded=!0;n.version='1.0';n.queue=[];t=a.createElement(e);t.async=!0;t.data-privacy-src=v;z=a.getElementsByTagName(e)[0];z.parentNode.insertBefore(t,z)}(window,document,'script','https://tags.srv.stackadapt.com/events.js');saq('ts', 'hqvUkGggBAQuL-fcnFloOA');

Valiltramiprosate is an investigational agent and not approved for use anywhere in the world. Statements in news stories may be aspirational.

Take A Pill For It! Approach to Alzheimer’s Disease

Alzheon CEO Martin Tolar interview with Bloomer Boomer

For privacy reasons YouTube needs your permission to be loaded. For more details, please see our Privacy Policy.

In this episode of “Boomer TV: Embrace Age, Empower Dreams Embrace Life,” Andy Asher, editor of BloomerBoomer.com visits with Martin Tolar, MD, PhD, Founder, President & CEO at Alzheon, Inc..

Source: bloomerboomer.com

What is Alzheon?
[00:51]

Will we see a cure?
[01:26]

A clear path forward.
[00:42]

More News

2024-08-26T11:04:59-04:00August 28th, 2019|

Share This Story, Choose Your Platform!

FacebookXRedditLinkedInTumblrPinterestVkEmail

Newsletter

Sign up for updates

Get the latest Alzheon news in your inbox.

Not seeing the signup form? An ad or privacy blocker may be hiding it – email info@alzheon.com and we’ll add you to the list.

Alzheon, Inc.
111 Speen Street, Suite 306
Framingham, MA 01701, USA
508-861-7709

© 2026 Alzheon, Inc. All rights reserved.

Privacy PolicyContact
This website uses cookies and third-party services. By clicking "ACCEPT", you confirm that you have read and are agreeing to our privacy policy and the use of ALL cookies. ACCEPT
Go to Top